Funding for this research was provided by:
National Center for Advancing Translational Sciences (UL1 TR001082)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (T32 AR007534)
National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK107905)
U.S. Department of Veterans Affairs (US) (VA MERIT IIR 14-083-03)
Michelson Charitable Trust
UC Denver Gastrointestinal and Liver Innate Immune Program
Text and Data Mining valid from 2018-07-20
Received: 23 April 2018
Accepted: 1 June 2018
First Online: 20 July 2018
Ethics approval and consent to participate
: All clinical investigations were conducted according to the principles expressed in the Declaration of Helsinki. The study protocol was approved by the Colorado Multiple Institutional Review Board. All patients provided written informed consent and authorization for release of personal health information. An independent safety officer was assigned and met every 12 months with the investigators to conduct safety reviews.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.